In Case You Haven't Heard…

Popular diabetes and weight loss drugs may do more than curb appetites — they may also help reduce the risk of dementia, according to new research, CBS News reported. Two studies that noted this unexpected effect were recently published in the journal JAMA Neurology , though neither were specifically designed to look at that risk. One looked at 26 different clinical trials of these medications while the other looked at health records of thousands of people on these medications. “These were not clinical trials specifically to look at dementia, but based on what they saw in those trials, there was a hint that these newer medications, like Ozempic, like Mounjaro, may reduce the risk of dementia in people who are on those drugs,” Dr. Céline Gounder, CBS News medical contributor and editor‐at‐large for public health at KFF Health News, said on “CBS Mornings” April 8. Gounder said it makes sense that these medications may potentially have this effect. “What we're seeing is there's this underlying mechanism of damage to blood vessels, inflammation, which is what's driving many of the chronic diseases we see — whether that's heart disease, kidney disease, damage to the brain, which can lead to stroke or dementia,” she said.

Publication Details

Journal
Mental Health Weekly
Published
2025-04-12
DOI
https://doi.org/10.1002/mhw.34416
Primary Topic
Pharmacology and Obesity Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In Case You Haven't Heard…

Mental Health Weekly
Pharmacology and Obesity Treatment
article

In Case You Haven't Heard…

article en

Abstract

Popular diabetes and weight loss drugs may do more than curb appetites — they may also help reduce the risk of dementia, according to new research, CBS News reported. Two studies that noted this unexpected effect were recently published in the journal JAMA Neurology , though neither were specifically designed to look at that risk. One looked at 26 different clinical trials of these medications while the other looked at health records of thousands of people on these medications. “These were not clinical trials specifically to look at dementia, but based on what they saw in those trials, there was a hint that these newer medications, like Ozempic, like Mounjaro, may reduce the risk of dementia in people who are on those drugs,” Dr. Céline Gounder, CBS News medical contributor and editor‐at‐large for public health at KFF Health News, said on “CBS Mornings” April 8. Gounder said it makes sense that these medications may potentially have this effect. “What we're seeing is there's this underlying mechanism of damage to blood vessels, inflammation, which is what's driving many of the chronic diseases we see — whether that's heart disease, kidney disease, damage to the brain, which can lead to stroke or dementia,” she said.

Mental Health WeeklyVol. 35(15)
Openalex Percentile: Top 91%
Pharmacology and Obesity Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.